APA
Duffield A. S., Ascierto M. L., Anders R. A., Taube J. M., Meeker A. K., Chen S., McMiller T. L., Phillips N. A., Xu H., Ogurtsova A., Berger A. E., Pardoll D. M., Topalian S. L. & Ambinder R. F. (2017). Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy. : Blood advances.
Chicago
Duffield Amy S, Ascierto Maria Libera, Anders Robert A, Taube Janis M, Meeker Alan K, Chen Shuming, McMiller Tracee L, Phillips Neil A, Xu Haiying, Ogurtsova Aleksandra, Berger Alan E, Pardoll Drew M, Topalian Suzanne L and Ambinder Richard F. 2017. Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy. : Blood advances.
Harvard
Duffield A. S., Ascierto M. L., Anders R. A., Taube J. M., Meeker A. K., Chen S., McMiller T. L., Phillips N. A., Xu H., Ogurtsova A., Berger A. E., Pardoll D. M., Topalian S. L. and Ambinder R. F. (2017). Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy. : Blood advances.
MLA
Duffield Amy S, Ascierto Maria Libera, Anders Robert A, Taube Janis M, Meeker Alan K, Chen Shuming, McMiller Tracee L, Phillips Neil A, Xu Haiying, Ogurtsova Aleksandra, Berger Alan E, Pardoll Drew M, Topalian Suzanne L and Ambinder Richard F. Th17 immune microenvironment in Epstein-Barr virus-negative Hodgkin lymphoma: implications for immunotherapy. : Blood advances. 2017.